Crux Biolabs
Stefan Cross is currently the Chief Executive Officer at Crux Biolabs since May 2023. Prior to this role, Stefan held various positions at several notable companies, including Redkite and Mayne Pharma. With a Bachelor's degree in Business Information Systems from the University of South Australia and an MBA in Corporate Strategy from Swinburne University of Technology, Stefan's extensive experience in the pharmaceutical industry has shaped their career progression from commercial management roles to executive leadership positions.
This person is not in any teams
Crux Biolabs
Crux Biolabs is an Australian bioanalytical laboratory specialising in PBMC processing, pharmacodynamics (biomarker, flow cytometry, ELISpot and ADA) and pharmacokinetics (large and small molecule) for clinical research. Our expert scientists can customise and validate a wide range of biomarker and cell assays in our ISO 17025 accredited lab in Melbourne, Australia. We also offer PBMC processing in Sydney with our dedicated satellite laboratory. We understand that each study is unique. That’s why we take pride in becoming an extension of your team to deliver the best outcome for your studies. Crux Biolabs - where science leads.